What is Ocular Therapeutix's current ratio?

Ocular Therapeutix (OCUL) reported current ratio of 14.8× in Q1 2026.

How has Ocular Therapeutix's current ratio changed year-over-year?

Ocular Therapeutix's current ratio increased by 44.8% year-over-year, from 10.2× to 14.8×.

What is the long-term trend for Ocular Therapeutix's current ratio?

Over 5 years (2020 to 2025), Ocular Therapeutix's current ratio has grown at a 10.8% compound annual growth rate (CAGR), from 9.2× to 15.4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ocular Therapeutix OCUL Current ratio

Current ratio at other companies

Regeneron PharmaceuticalsREGN

3.6×-1.4×

Bausch + LombBLCO

1.5×0.0×

HRO

HarrowHROW

2.5×+1.6×

Tarsus Pharmaceuticals, Inc.TARS

3.7×-1.8×

Kodiak Sciences IncKOD

3.5×-1.1×

Ultragenyx PharmaceuticalRARE

2×-0.4×

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

total current assets/total current liabilities=14.8×

Based on the most recent quarter.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's current ratio?: Ocular Therapeutix (OCUL) reported current ratio of 14.8× in Q1 2026.
How has Ocular Therapeutix's current ratio changed year-over-year?: Ocular Therapeutix's current ratio increased by 44.8% year-over-year, from 10.2× to 14.8×.
What is the long-term trend for Ocular Therapeutix's current ratio?: Over 5 years (2020 to 2025), Ocular Therapeutix's current ratio has grown at a 10.8% compound annual growth rate (CAGR), from 9.2× to 15.4×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.